Searching. Please wait…
1579
37
171
29274
4420
2604
347
391
Abstract: Non-alcoholic fatty liver disease (NAFLD) is currently the most prevalent cause of chronic liver disease (CLD). Currently, the only therapeutic recommendation available is a lifestyle change. However, adherence to this approach is often difficult to guarantee. Alteration of the microbiota and an increase in intestinal permeability seem to be key in the development and progression of NAFLD. Therefore, the manipulation of microbiota seems to provide a promising therapeutic strategy. One way to do so is through faecal microbiota transplantation (FMT). Here, we summarize the key aspects of FMT, detail its current indications and highlight the most recent advances in NAFLD
Fuente: International journal of molecular sciences, 2023, 24(7), 6123
Publisher: MPDI
Year of publication: 2023
No. of pages: 19
Publication type: Article
DOI: 10.3390/ijms24076123
ISSN: 1661-6596,1422-0067
Publication Url: https://doi.org/10.3390/ ijms24076123
Citations in Google Scholar
Consult in UCrea Read publication
BARRIO, MARÍA DEL
LAVÍN, LUCÍA
SANTOS-LASO, ÁLVARO
MARIA TERESA ARIAS LOSTE
ODRIOZOLA, AITOR
RODRIGUEZ-DUQUE, JUAN CARLOS
RIVAS, CORAL
IRUZUBIETA, PAULA
JAVIER CRESPO GARCIA
Back